CytomX Therapeutics
CTMX
CTMX
49 hedge funds and large institutions have $226M invested in CytomX Therapeutics in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
37% less capital invested
Capital invested by funds: $360M → $226M (-$134M)
Holders
49
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.29M | |
| 2 | +$761K | |
| 3 | +$645K | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$411K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$399K |
Top Sellers
| 1 | -$485K | |
| 2 | -$444K | |
| 3 | -$324K | |
| 4 |
Goldman Sachs
New York
|
-$319K |
| 5 |
QSS
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
|
-$300K |